DTL
PSTX

Dynamic Technology Lab’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Dynamic Technology Lab’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,031
Closed -$79K – 1433
2024
Q2 		$79K Buy
+27,031
New +$73.9K 0.01% 864
2024
Q1 		– Sell
-10,459
Closed -$36K – 1502
2023
Q4 		$36K Buy
+10,459
New +$26.9K ﹤0.01% 977
2023
Q2 		– Sell
-33,807
Closed -$104K – 1492
2023
Q1 		$104K Buy
33,807
+15,094
+81% +$90.5K 0.01% 970
2022
Q4 		$99K Buy
+18,713
New +$85.5K 0.01% 994

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Dynamic Technology Lab's PSTX Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q3 2024, closing a stake of 27,031 shares — an estimated $79K sold.

Dynamic Technology Lab first reported a position in PSTX in Q4 2022 and held it in 4 quarters. The position peaked at $104K in Q1 2023. 96 funds tracked by Wall St. Rank hold PSTX as of Q3 2024.

  • Dynamic Technology Lab reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 27,031 Poseida Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $79K.
  • Dynamic Technology Lab first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Dynamic Technology Lab's Poseida Therapeutics, Inc. Common Stock position peaked at $104K in Q1 2023.
  • 96 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.